Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search...
Cmd K
Search...
Cmd K
← Back to rankings
BOLT
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w low +17.9%
BOLT
Bolt Biotherapeutics, Inc. Common Stock
☁️ News word cloud
Top words across the last 50 articles for this ticker.
biotherapeutics
2023
1001
clinical
nasdaq
cancer
class
investors
lawsuit
action
phase
securities
treatment
about
trading
false
misleading
statements
firm
drug
StonvexStonvexStonvexStonvex